For example, lycopene and astaxanthin have been shown to inhibit the NF-κB pathway, reducing the activation of downstream pro-inflammatory genes and inflammation caused by obesity, cancer, and other diseases [23]. Here, NFKB1 is linked to obesity due to melanocortin 4 receptor deficiency.